Compare ROL & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROL | STE |
|---|---|---|
| Founded | 1948 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 25.9B |
| IPO Year | N/A | 1992 |
| Metric | ROL | STE |
|---|---|---|
| Price | $60.66 | $255.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $66.20 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 2.4M | 616.3K |
| Earning Date | 02-11-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.20% | 0.99% |
| EPS Growth | 9.81 | ★ 59.39 |
| EPS | 1.06 | ★ 6.97 |
| Revenue | $3,680,306,000.00 | ★ $5,702,415,000.00 |
| Revenue This Year | $12.58 | $9.61 |
| Revenue Next Year | $9.23 | $6.23 |
| P/E Ratio | $57.04 | ★ $36.63 |
| Revenue Growth | ★ 11.17 | 7.08 |
| 52 Week Low | $45.34 | $200.98 |
| 52 Week High | $61.84 | $268.60 |
| Indicator | ROL | STE |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 49.83 |
| Support Level | $59.62 | $249.99 |
| Resistance Level | $61.24 | $255.94 |
| Average True Range (ATR) | 1.18 | 4.68 |
| MACD | 0.00 | -0.55 |
| Stochastic Oscillator | 76.88 | 39.92 |
Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. They also have a litany of other brands, which they use to pursue customers via alternative sales channels. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.